{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:39:11Z","timestamp":1792564751410,"version":"4.5.0"},"reference-count":304,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund (FWF) with a D-A-CH project","doi-asserted-by":"publisher","award":["I 3877-B21"],"award-info":[{"award-number":["I 3877-B21"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","award":["2021.106.1"],"award-info":[{"award-number":["2021.106.1"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Kallikrein-related peptidases (KLKs) are hallmarks of higher vertebrates, in particular of mammals. While the 15 human KLKs occur in nearly all tissues and body fluids and participate in many physiological processes, they are also involved in severe diseases. Among them are prostate, ovarian and breast cancer, as well as inherited skin and neurological disorders. Thus, KLKs have become targets for inhibitory compounds in academic and commercial research. The most prominent clinical biomarker and anti-cancer target for various approaches is PSA\/KLK3. Already in the distant past, natural crude extracts were the source of medicine, while purified natural compounds and their derivatives are still the basis of about 50% of all pharmaceuticals. Nevertheless, structure-based rational design and high-throughput screening of natural and synthetic compound libraries are highly effective approaches for discovering lead compounds in the development of new drugs. Recently, computer-aided virtual or in silico screening has become a rapid method for such discoveries when combined with in vitro assays using protein targets or tests in cell cultures. To date, the successful implementation of artificial intelligence (AI) in the biosciences has significantly contributed to drug discovery. Our review focuses on state-of-the-art strategies and techniques in the context of KLK targets.<\/jats:p>","DOI":"10.3390\/ijms27010225","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:50:21Z","timestamp":1766710221000},"page":"225","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Drug Discovery Strategies for Kallikrein-Related Peptidases"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5366-7859","authenticated-orcid":false,"given":"Tobias","family":"Dreyer","sequence":"first","affiliation":[{"name":"Department of Gynecology and Obstetrics, Technical University of Munich, 81675 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9933-8938","authenticated-orcid":false,"given":"Daniela","family":"Schuster","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Paracelsus Medical University, Strubergasse 21, 5020 Salzburg, Austria"},{"name":"Research and Innovation Center for Regenerative Medicine and Novel Therapies, Paracelsus Medical University, Strubergasse 21, 5020 Salzburg, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0167-793X","authenticated-orcid":false,"given":"Viktor","family":"Magdolen","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Technical University of Munich, 81675 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2430-1970","authenticated-orcid":false,"given":"Peter","family":"Goettig","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Paracelsus Medical University, Strubergasse 21, 5020 Salzburg, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Pavlopoulou, A., Pampalakis, G., Michalopoulos, I., and Sotiropoulou, G. (2010). Evolutionary History of Tissue Kallikreins. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0013781"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Koumandou, V.L., and Scorilas, A. (2013). Evolution of the Plasma and Tissue Kallikreins, and Their Alternative Splicing Isoforms. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0068074"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1515\/BC.2001.001","article-title":"Kinins 1925\u20132000","volume":"382","author":"Fritz","year":"2001","journal-title":"Biol. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"D503","DOI":"10.1093\/nar\/gkt953","article-title":"MEROPS: The Database of Proteolytic Enzymes, Their Substrates and Inhibitors","volume":"42","author":"Rawlings","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1373\/clinchem.2007.088104","article-title":"Distribution of 15 Human Kallikreins in Tissues and Biological Fluids","volume":"53","author":"Shaw","year":"2007","journal-title":"Clin. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/14728222.2018.1512587","article-title":"Kallikrein-Related Peptidases Represent Attractive Therapeutic Targets for Ovarian Cancer","volume":"22","author":"Loessner","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Goettig, P. (2016). Effects of Glycosylation on the Enzymatic Activity and Mechanisms of Proteases. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17121969"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1515\/hsz-2014-0123","article-title":"KLKs and Their Hormone-like Signaling Actions: A New Life for the PSA-KLK Family","volume":"395","author":"Hollenberg","year":"2014","journal-title":"Biol. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"27273","DOI":"10.1074\/jbc.M201534200","article-title":"The Structure of Human Prokallikrein 6 Reveals a Novel Activation Mechanism for the Kallikrein Family","volume":"277","author":"Sotiropoulou","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jmb.2011.10.007","article-title":"Crystal Structure of Human Prostate-Specific Antigen in a Sandwich Antibody Complex","volume":"414","author":"Stura","year":"2011","journal-title":"J. Mol. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.biochi.2010.06.022","article-title":"Natural and Synthetic Inhibitors of Kallikrein-Related Peptidases (KLKs)","volume":"92","author":"Goettig","year":"2010","journal-title":"Biochimie"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biochi.2019.09.004","article-title":"Surface Loops of Trypsin-like Serine Proteases as Determinants of Function","volume":"166","author":"Goettig","year":"2019","journal-title":"Biochimie"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.1038\/s41598-018-29058-6","article-title":"Structural Determinants of Specificity and Regulation of Activity in the Allosteric Loop Network of Human KLK8\/Neuropsin","volume":"8","author":"Debela","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1074\/jbc.M115.691097","article-title":"A Single Glycan at the 99-Loop of Human Kallikrein-Related Peptidase 2 Regulates Activation and Enzymatic Activity","volume":"291","author":"Guo","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"8915809","DOI":"10.1155\/2016\/8915809","article-title":"Analysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate Hyperplasia","volume":"2016","author":"Hsiao","year":"2016","journal-title":"Dis. Markers"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1373\/clinchem.2018.295790","article-title":"Prostate Cancer Risk-Associated Single-Nucleotide Polymorphism Affects Prostate-Specific Antigen Glycosylation and Its Function","volume":"65","author":"Srinivasan","year":"2019","journal-title":"Clin. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/pmic.201100371","article-title":"Separation of Kallikrein 6 Glycoprotein Subpopulations in Biological Fluids by Anion-Exchange Chromatography Coupled to ELISA and Identification by Mass Spectrometry","volume":"12","author":"Kuzmanov","year":"2012","journal-title":"Proteomics"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1074\/jbc.M110.125310","article-title":"Kallikrein-Related Peptidase-8 (KLK8) Is an Active Serine Protease in Human Epidermis and Sweat and Is Involved in a Skin Barrier Proteolytic Cascade","volume":"286","author":"Eissa","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1080\/14728222.2024.2415014","article-title":"Kallikrein-Related Peptidases: Mechanistic Understanding for Potential Therapeutic Targeting in Cancer","volume":"28","author":"Daneva","year":"2024","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/14737159.2021.1924680","article-title":"The Prognostic and Diagnostic Potential of Kallikrein-Related Peptidases in Ovarian Cancer","volume":"21","author":"Riedel","year":"2021","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1515\/hsz-2011-0273","article-title":"Epigenetic Regulation of Kallikrein-Related Peptidases: There Is a Whole New World out There","volume":"393","author":"Pasic","year":"2012","journal-title":"Biol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1373\/clinchem.2018.295824","article-title":"MicroRNA-3162-5p-Mediated Crosstalk between Kallikrein Family Members Including Prostate-Specific Antigen in Prostate Cancer","volume":"65","author":"Matin","year":"2019","journal-title":"Clin. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1515\/bc.2010.037","article-title":"Natural and Engineered Kallikrein Inhibitors: An Emerging Pharmacopoeia","volume":"391","author":"Swedberg","year":"2010","journal-title":"Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/med.21451","article-title":"Inhibitors of Kallikrein-Related Peptidases: An Overview","volume":"38","author":"Masurier","year":"2018","journal-title":"Med. Res. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/er.2009-0034","article-title":"Kallikreins on Steroids: Structure, Function, and Hormonal Regulation of Prostate-Specific Antigen and the Extended Kallikrein Locus","volume":"31","author":"Lawrence","year":"2010","journal-title":"Endocr. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1073\/pnas.0400782101","article-title":"A Gene Atlas of the Mouse and Human Protein-Encoding Transcriptomes","volume":"101","author":"Su","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"eaal3321","DOI":"10.1126\/science.aal3321","article-title":"A Subcellular Map of the Human Proteome","volume":"356","author":"Thul","year":"2017","journal-title":"Science"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/pro.4211","article-title":"Protein Data Bank Japan: Celebrating Our 20th Anniversary during a Global Pandemic as the Asian Hub of Three Dimensional Macromolecular Structural Data","volume":"31","author":"Bekker","year":"2022","journal-title":"Protein Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13321-016-0155-1","article-title":"Molmil: A Molecular Viewer for the PDB and Beyond","volume":"8","author":"Bekker","year":"2016","journal-title":"J. Cheminform."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1006\/jmbi.1993.1098","article-title":"Refined 1\u00b78 \u00c5 X-Ray Crystal Structure of Astacin, a Zinc-Endopeptidase from the Crayfish Astacus Astacus L.: Structure Determination, Refinement, Molecular Structure and Comparison with Thermolysin","volume":"229","author":"Huber","year":"1993","journal-title":"J. Mol. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Freymann, E., Hobaiter, C., Huffman, M.A., Klein, H., Muhumuza, G., Reynolds, V., Slania, N.E., Soldati, A., Yikii, E.R., and Zuberb\u00fchler, K. (2025). Self-Directed and Prosocial Wound Care, Snare Removal, and Hygiene Behaviors amongst the Budongo Chimpanzees. Front. Ecol. Evol., 13.","DOI":"10.3389\/fevo.2025.1540922"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijpp.2018.07.006","article-title":"Possible Evidence for Care and Treatment in the Tyrolean Iceman","volume":"25","author":"Zink","year":"2019","journal-title":"Int. J. Paleopathol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Elsayad, K. (2023). What Ancient Egyptian Medicine Can Teach Us. JCO Glob. Oncol., e2300146.","DOI":"10.1200\/GO.23.00146"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"113159","DOI":"10.1016\/j.jep.2020.113159","article-title":"Historical and Modern Research on Propolis and Its Application in Wound Healing and Other Fields of Medicine and Contributions by Polish Studies","volume":"262","author":"Rojczyk","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/0973-7847.134229","article-title":"Polyherbal Formulation: Concept of Ayurveda","volume":"8","author":"Parasuraman","year":"2014","journal-title":"Pharmacogn. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"112491","DOI":"10.1016\/j.jep.2019.112491","article-title":"\u201cShanghuo\u201d Increases Disease Susceptibility: Modern Significance of an Old TCM Theory","volume":"250","author":"Pan","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1096\/fj.06-0803ufm","article-title":"Arab Science in the Golden Age (750\u20131258 C.E.) and Today","volume":"20","author":"Falagas","year":"2006","journal-title":"FASEB J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4103\/1995-705X.105744","article-title":"The Air of History (Part II) Medicine in the Middle Ages","volume":"13","author":"Hajar","year":"2012","journal-title":"Heart Views"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Hacker, M., Messer, W., and Bachmann, K.B.T.-P. (2009). Chapter 1\u2014History of Pharmacology\u2014From Antiquity to the Twentieth Century. Pharmacology, Academic Press.","DOI":"10.1016\/B978-0-12-369521-5.00001-4"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF03159978","article-title":"Early Clinical Neurochemistry of CNS-Active Drugs","volume":"17","author":"Sourkes","year":"1992","journal-title":"Mol. Chem. Neuropathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2018.10.008","article-title":"The First 3500 years of Aspirin History from Its Roots\u2014A Concise Summary","volume":"113","author":"Montinari","year":"2019","journal-title":"Vasc. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/9780470559277.ch110252","article-title":"Selecting, Acquiring, and Using Small Molecule Libraries for High-Throughput Screening","volume":"4","author":"Dandapani","year":"2012","journal-title":"Curr. Protoc. Chem. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1192\/bjp.195.5.456","article-title":"The Original \u2018Magic Bullet\u2019 Is 100 Years Old","volume":"195","author":"Heynick","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"ref_44","first-page":"137","article-title":"Drug Discovery and Development: A Historical Overview, Current Challenges and Perspectives","volume":"8","author":"Yu","year":"2024","journal-title":"Life Sci. Med. Biomed."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10822-007-9142-y","article-title":"Computer-Aided Drug Design: The next 20 Years","volume":"21","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bcp.2013.09.011","article-title":"The Fall and Rise of Pharmacology\u2014(Re-)Defining the Discipline?","volume":"87","author":"Winquist","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1089\/adt.2004.2.675","article-title":"History, Evolution, and Trends in Compound Management for High Throughput Screening","volume":"2","author":"Archer","year":"2004","journal-title":"ASSAY Drug Dev. Technol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Zhou, J.Z. (2011). Historical Overview of Chemical Library Design. Chemical Library Design, Humana Press.","DOI":"10.1007\/978-1-60761-931-4"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/jm00121a001","article-title":"Rational Design of Enzyme Inhibitors: Multisubstrate Analog Inhibitors","volume":"32","author":"Broom","year":"1989","journal-title":"J. Med. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.shpsc.2005.07.003","article-title":"Integrating Research and Development: The Emergence of Rational Drug Design in the Pharmaceutical Industry","volume":"36","author":"Adam","year":"2005","journal-title":"Stud. Hist. Philos. Sci. Part C Stud. Hist. Philos. Biol. Biomed. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1039\/D0MD00375A","article-title":"Fragment-Based Drug Discovery: Opportunities for Organic Synthesis","volume":"12","author":"Denis","year":"2021","journal-title":"RSC Med. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/med.2610130305","article-title":"Peptidomimetics Derived from Natural Products","volume":"13","author":"Wiley","year":"1993","journal-title":"Med. Res. Rev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-3441-7_1","article-title":"Computer-Aided Drug Discovery and Design: Recent Advances and Future Prospects","volume":"2714","author":"Talevi","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Szil\u00e1gyi, K., Flachner, B., Hajd\u00fa, I., Szaszk\u00f3, M., Dobi, K., L\u0151rincz, Z., Cseh, S., and Dorm\u00e1n, G. (2021). Rapid Identification of Potential Drug Candidates from Multi-Million Compounds\u2019 Repositories. Combination of 2D Similarity Search with 3D Ligand\/Structure Based Methods and In Vitro Screening. Molecules, 26.","DOI":"10.3390\/molecules26185593"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1021\/acs.jcim.2c01253","article-title":"ZINC-22\u2014A Free Multi-Billion-Scale Database of Tangible Compounds for Ligand Discovery","volume":"63","author":"Tingle","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"D1633","DOI":"10.1093\/nar\/gkae1075","article-title":"BindingDB in 2024: A FAIR Knowledgebase of Protein-Small Molecule Binding Data","volume":"53","author":"Liu","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","article-title":"The ChEMBL Database in 2023: A Drug Discovery Platform Spanning Multiple Bioactivity Data Types and Time Periods","volume":"52","author":"Zdrazil","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","article-title":"PubChem 2025 Update","volume":"53","author":"Kim","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1007\/s11030-024-10979-6","article-title":"Ligand and Structure-Based Virtual Screening Approaches in Drug Discovery: Minireview","volume":"29","author":"Marinho","year":"2025","journal-title":"Mol. Divers."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/ci049885e","article-title":"LigandScout:\u2009 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters","volume":"45","author":"Wolber","year":"2005","journal-title":"J. Chem. Inf. Model."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/prot.10465","article-title":"Improved Protein\u2013Ligand Docking Using GOLD","volume":"52","author":"Verdonk","year":"2003","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/17460441.2025.2508866","article-title":"On the Application of Artificial Intelligence in Virtual Screening","volume":"20","author":"Thaingtamtanha","year":"2025","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s11030-021-10298-0","article-title":"Structure-Based Virtual Screening, in Silico Docking, ADME Properties Prediction and Molecular Dynamics Studies for the Identification of Potential Inhibitors against SARS-CoV-2 Mpro","volume":"26","author":"Mohan","year":"2022","journal-title":"Mol. Divers."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.1021\/acs.jcim.3c00939","article-title":"Identification of Novel \u03b2-Tubulin Inhibitors Using a Combined In Silico\/In Vitro Approach","volume":"63","author":"Horgan","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Scalia, G., Rutherford, S.T., Lu, Z., Buchholz, K.R., Skelton, N., Chuang, K., Diamant, N., H\u00fctter, J.-C., Luescher, J.-M., and Miu, A. (2025). Deep-Learning-Based Virtual Screening of Antibacterial Compounds. Nat. Biotechnol.","DOI":"10.1038\/s41587-025-02814-6"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"20406223211014025","DOI":"10.1177\/20406223211014025","article-title":"Alpha-1 Antitrypsin Deficiency Research and Emerging Treatment Strategies: What\u2019s down the Road?","volume":"12","author":"Rahaghi","year":"2021","journal-title":"Ther. Adv. Chronic Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0030-1248729","article-title":"Prohemostatic Therapy: The Rise and Fall of Aprotinin","volume":"36","author":"Zacharski","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2125.2011.03916.x","article-title":"Direct Thrombin Inhibitors","volume":"72","author":"Lee","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1002\/1878-0261.13513","article-title":"Serine Protease Inhibitors Decrease Metastasis in Prostate, Breast, and Ovarian Cancers","volume":"17","author":"Sananes","year":"2023","journal-title":"Mol. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1248\/bpb.b24-00369","article-title":"Sunflower Trypsin Monocyclic Inhibitor Selected for the Main Protease of SARS-CoV-2 by Phage Display","volume":"47","author":"Ferreira","year":"2024","journal-title":"Biol. Pharm. Bull."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1021\/acschembio.6b00486","article-title":"Constrained Cyclic Peptides as Immunomodulatory Inhibitors of the CD2:CD58 Protein\u2013Protein Interaction","volume":"11","author":"Sable","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"140562","DOI":"10.1016\/j.bbapap.2020.140562","article-title":"Structure of an Affinity-Matured Inhibitory Recombinant Fab against Urokinase Plasminogen Activator Reveals Basis of Potency and Specificity","volume":"1869","author":"Sevillano","year":"2021","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Proteins Proteom."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1042\/BJ20090010","article-title":"Specific Inhibition of Tissue Kallikrein 1 with a Human Monoclonal Antibody Reveals a Potential Role in Airway Diseases","volume":"422","author":"Sexton","year":"2009","journal-title":"Biochem. J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"eabp9159","DOI":"10.1126\/scitranslmed.abp9159","article-title":"Dual Antibody Inhibition of KLK5 and KLK7 for Netherton Syndrome and Atopic Dermatitis","volume":"14","author":"Chiu","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"15156","DOI":"10.1074\/jbc.M116.732503","article-title":"A Camelid-Derived Antibody Fragment Targeting the Active Site of a Serine Protease Balances between Inhibitor and Substrate Behavior","volume":"291","author":"Oldenburg","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"169101","DOI":"10.1016\/j.jmb.2025.169101","article-title":"Allosteric Anti-KLK4 Antibody Development for Targeted Anti-Cancer Effects in Ovarian Carcinoma","volume":"437","author":"Afratis","year":"2025","journal-title":"J. Mol. Biol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Liu, C., and He, W. (2025). Recent Advances in the Development of Functional Nucleic Acid Biosensors Based on Aptamer-Rolling Circle Amplification. Molecules, 30.","DOI":"10.3390\/molecules30112375"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"25789","DOI":"10.1021\/jacs.3c09497","article-title":"Functionally Enhanced XNA Aptamers Discovered by Parallelized Library Screening","volume":"145","author":"Yu","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.ymthe.2025.02.045","article-title":"Clinical Applications of Oligonucleotides for Cancer Therapy","volume":"33","author":"DeFranciscis","year":"2025","journal-title":"Mol. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/MOH.0000000000000452","article-title":"Emerging Applications of Aptamers for Anticoagulation and Hemostasis","volume":"25","author":"Chabata","year":"2018","journal-title":"Curr. Opin. Hematol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"8052","DOI":"10.1093\/nar\/gkw725","article-title":"Evoking Picomolar Binding in RNA by a Single Phosphorodithioate Linkage","volume":"44","author":"Abeydeera","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clinbiochem.2021.03.014","article-title":"The Use of Aptamers in Prostate Cancer: A Systematic Review of Theranostic Applications","volume":"93","year":"2021","journal-title":"Clin. Biochem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"128871","DOI":"10.1016\/j.talanta.2025.128871","article-title":"Aptamer-Based PSA Biosensing Technology: From Nanomaterials to CRISPR-Diagnostics Technology","volume":"298","author":"Guo","year":"2026","journal-title":"Talanta"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"151638","DOI":"10.1016\/j.bbrc.2025.151638","article-title":"In Silico Maturation of DNA Aptamer against the Prostate-Specific Antigen (PSA) and Kinetic Analysis","volume":"759","author":"Huang","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.tips.2012.09.005","article-title":"Targeting the Kallikrein-Related Peptidases for Drug Development","volume":"33","author":"Sotiropoulou","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Sotiropoulou, G., Zingkou, E., Bisyris, E., and Pampalakis, G. (2022). Activity-Based Probes for Proteases Pave the Way to Theranostic Applications. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14050977"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/15384047.2022.2074775","article-title":"Novel Specific Activity-Based Probes Validate KLK Proteases as Druggable Targets","volume":"23","author":"Sotiropoulou","year":"2022","journal-title":"Cancer Biol. Ther."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1046\/j.1523-1755.2000.00219.x","article-title":"Human Tissue Kallikrein Gene Delivery Attenuates Hypertension, Renal Injury, and Cardiac Remodeling in Chronic Renal Failure","volume":"58","author":"Wolf","year":"2000","journal-title":"Kidney Int."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1515\/hsz-2018-0114","article-title":"Kallikrein-Related Peptidases in Lung Diseases","volume":"399","author":"Iochmann","year":"2018","journal-title":"Biol. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/10408363.2022.2102578","article-title":"The Therapeutic Relevance of the Kallikrein-Kinin Axis in SARS-Cov-2-Induced Vascular Pathology","volume":"60","author":"Sohaei","year":"2023","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/gbe\/evs111","article-title":"Birth-and-Death of KLK3 and KLK2 in Primates: Evolution Driven by Reproductive Biology","volume":"4","author":"Marques","year":"2012","journal-title":"Genome Biol. Evol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1074\/mcp.M115.057695","article-title":"Quantification of Human Kallikrein-Related Peptidases in Biological Fluids by Multiplatform Targeted Mass Spectrometry Assays","volume":"15","author":"Karakosta","year":"2016","journal-title":"Mol. Cell. Proteom. MCP"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1515\/BC.2008.080","article-title":"Functions of KLK4 and MMP-20 in Dental Enamel Formation","volume":"389","author":"Lu","year":"2008","journal-title":"Biol. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Lee, Y., Zhang, H., Seymen, F., Kim, Y.J., Kasimoglu, Y., Koruyucu, M., Simmer, J.P., Hu, J.C.-C., and Kim, J.-W. (2022). Novel KLK4 Mutations Cause Hypomaturation Amelogenesis Imperfecta. J. Pers. Med., 12.","DOI":"10.3390\/jpm12020150"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1091\/mbc.e07-02-0124","article-title":"LEKTI Fragments Specifically Inhibit KLK5, KLK7, and KLK14 and Control Desquamation through a pH-Dependent Interaction","volume":"18","author":"Deraison","year":"2007","journal-title":"Mol. Biol. Cell"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Zani, M.B., Sant\u2019Ana, A.M., Tognato, R.C., Chagas, J.R., and Puzer, L. (2022). Human Tissue Kallikreins-Related Peptidases Are Targets for the Treatment of Skin Desquamation Diseases. Front. Med., 8.","DOI":"10.3389\/fmed.2021.777619"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1021\/bi015781a","article-title":"Enzymatic Properties of Rat Myelencephalon-Specific Protease","volume":"41","author":"Blaber","year":"2002","journal-title":"Biochemistry"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/157016310793180611","article-title":"Robertson Human Kallikrein 6 Cerebrospinal Levels Are Elevated in Multiple Sclerosis","volume":"7","author":"Hebb","year":"2010","journal-title":"Curr. Drug Discov. Technol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1440-1819.2000.00731.x","article-title":"Localization of a Novel Type Trypsin-like Serine Protease, Neurosin, in Brain Tissues of Alzheimer\u2019s Disease and Parkinson\u2019s Disease","volume":"54","author":"Ogawa","year":"2000","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1007\/s00018-013-1258-8","article-title":"Vaspin Inhibits Kallikrein 7 by Serpin Mechanism","volume":"70","author":"Heiker","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1113\/jphysiol.2005.098715","article-title":"Neuropsin Is Essential for Early Processes of Memory Acquisition and Schaffer Collateral Long-Term Potentiation in Adult Mouse Hippocampus in Vivo","volume":"570","author":"Tamura","year":"2006","journal-title":"J. Physiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/jid.2012.18","article-title":"Kallikrein-Related Peptidase 8\u2013Dependent Skin Wound Healing Is Associated with Upregulation of Kallikrein-Related Peptidase 6 and PAR2","volume":"132","author":"Kishibe","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1038\/npp.2008.29","article-title":"Genetic Variations of Human Neuropsin Gene and Psychiatric Disorders: Polymorphism Screening and Possible Association with Bipolar Disorder and Cognitive Functions","volume":"33","author":"Izumi","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clinbiochem.2019.12.015","article-title":"Kallikrein-Related Peptidases Protein Expression in Lymphoid Tissues Suggests Potential Implications in Immune Response","volume":"77","author":"Filippou","year":"2020","journal-title":"Clin. Biochem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/NEN.0000000000000007","article-title":"Kallikrein Cascades in Traumatic Spinal Cord Injury: In Vitro Evidence for Roles in Axonopathy and Neuron Degeneration","volume":"72","author":"Radulovic","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40035-019-0168-6","article-title":"Kallikrein-Related Peptidases 6 and 10 Are Elevated in Cerebrospinal Fluid of Patients with Alzheimer\u2019s Disease and Associated with CSF-TAU and FDG-PET","volume":"8","author":"Goldhardt","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e64018","DOI":"10.1002\/ajmg.a.64018","article-title":"KLK11-Related Disorder of Cornification Presenting as Inflammatory Skin Disease: A Familial Case Report and Literature Review","volume":"197","author":"Eiumtrakul","year":"2025","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1096\/fj.13-237503","article-title":"Angiogenesis Stimulated by Human Kallikrein-Related Peptidase 12 Acting via a Platelet-Derived Growth Factor B-Dependent Paracrine Pathway","volume":"28","author":"Kryza","year":"2014","journal-title":"FASEB J."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"17399","DOI":"10.1074\/jbc.M112.440362","article-title":"Cleavage Activation of Human-Adapted Influenza Virus Subtypes by Kallikrein-Related Peptidases 5 and 12","volume":"288","author":"Hamilton","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.bbrc.2011.05.022","article-title":"Epigenetic Activation of Human Kallikrein 13 Enhances Malignancy of Lung Adenocarcinoma by Promoting N-Cadherin Expression and Laminin Degradation","volume":"409","author":"Chou","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"18753","DOI":"10.1074\/jbc.M116.722942","article-title":"Gingipains of Porphyromonas Gingivalis Affect the Stability and Function of Serine Protease Inhibitor of Kazal-Type 6 (SPINK6), a Tissue Inhibitor of Human Kallikreins","volume":"291","author":"Plaza","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clinbiochem.2018.06.017","article-title":"Expression Profile of Human Tissue Kallikrein 15 Provides Preliminary Insights into Its Roles in the Prostate and Testis","volume":"59","author":"Filippou","year":"2018","journal-title":"Clin. Biochem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.clinbiochem.2018.06.007","article-title":"Biochemical Characterization of Human Tissue Kallikrein 15 and Examination of Its Potential Role in Cancer","volume":"58","author":"Filippou","year":"2018","journal-title":"Clin. Biochem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"113343","DOI":"10.1016\/j.isci.2025.113343","article-title":"KLK15 Alters Connective Tissues in Hypermobile Ehlers-Danlos Syndrome","volume":"28","author":"Gensemer","year":"2025","journal-title":"iScience"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Sato, A., Takagi, K., Yoshimura, A., Tsukamoto, W., Yamaguchi-Tanaka, M., Miki, Y., Ebata, A., Miyashita, M., and Suzuki, T. (2023). Kallikrein-Related Peptidase 12 (KLK12) in Breast Cancer as a Favorable Prognostic Marker. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24098419"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2014.12.003","article-title":"Critical Insights into the Beneficial and Protective Actions of the Kallikrein\u2013Kinin System","volume":"64","author":"Regoli","year":"2015","journal-title":"Vasc. Pharmacol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"100925","DOI":"10.1016\/j.gim.2023.100925","article-title":"Defining the Clinical Validity of Genes Reported to Cause Pulmonary Arterial Hypertension","volume":"25","author":"Welch","year":"2023","journal-title":"Genet. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cca.2013.04.017","article-title":"Tissue Kallikrein Is Related to the Severity of Coronary Artery Disease","volume":"423","author":"Yao","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/ATVBAHA.108.182139","article-title":"Critical Role of Tissue Kallikrein in Vessel Formation and Maturation","volume":"29","author":"Stone","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/j.2040-4603.2011.tb00347.x","article-title":"The Kallikrein-Kinin System as a Regulator of Cardiovascular and Renal Function","volume":"1","author":"Rhaleb","year":"2011","journal-title":"Compr. Physiol."},{"key":"ref_122","first-page":"1177","article-title":"Genetically-modified Stem Cells in Treatment of Human Diseases: Tissue Kallikrein (KLK1)-based Targeted Therapy (Review)","volume":"41","author":"Devetzi","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"139","DOI":"10.18203\/2349-3259.ijct20174861","article-title":"Safety, Tolerability and Pharmacokinetic Profile of Recombinant Human Tissue Kallikrein, DM199, after Intravenous and Subcutaneous Administration in Healthy Volunteers","volume":"4","author":"Duan","year":"2017","journal-title":"Int. J. Clin. Trials"},{"key":"ref_124","first-page":"373","article-title":"Efficacy of Urinary Kallidinogenase Plus Intravenous Recombinant Tissue Plasminogen Activator for Stroke Patients With Extended Window: A Retrospective Analysis","volume":"28","author":"Li","year":"2023","journal-title":"Neurol"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1161\/STROKEAHA.124.048858","article-title":"Recombinant Human Tissue Kallikrein-1 for Treating Acute Ischemic Stroke and Preventing Recurrence","volume":"56","author":"Kasner","year":"2025","journal-title":"Stroke"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"L1127","DOI":"10.1152\/ajplung.00379.2018","article-title":"Tissue Kallikrein Regulates Alveolar Macrophage Apoptosis Early in Influenza Virus Infection","volume":"316","author":"Magnen","year":"2019","journal-title":"Am. J. Physiol. -Lung Cell. Mol. Physiol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1128\/AAC.00065-15","article-title":"Kallistatin Ameliorates Influenza Virus Pathogenesis by Inhibition of Kallikrein-Related Peptidase 1-Mediated Cleavage of Viral Hemagglutinin","volume":"59","author":"Leu","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Sudadech, P., Roytrakul, S., Kaewprasert, O., Sirichoat, A., Chetchotisakd, P., Kanthawong, S., and Faksri, K. (2021). Assessment of in Vitro Activities of Novel Modified Antimicrobial Peptides against Clarithromycin Resistant Mycobacterium Abscessus. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0260003"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"104195","DOI":"10.1016\/j.ebiom.2022.104195","article-title":"Dysregulation of the Kallikrein-Kinin System in Bronchoalveolar Lavage Fluid of Patients with Severe COVID-19","volume":"83","author":"Martens","year":"2022","journal-title":"eBioMedicine"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13073-019-0685-z","article-title":"Novel Risk Genes and Mechanisms Implicated by Exome Sequencing of 2572 Individuals with Pulmonary Arterial Hypertension","volume":"11","author":"Zhu","year":"2019","journal-title":"Genome Med."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Ma, L., Wu, J., Zheng, Y., Shu, Z., Wei, Z., Sun, Y., Carrell, R.W., and Zhou, A. (2020). Heparin Blocks the Inhibition of Tissue Kallikrein 1 by Kallistatin through Electrostatic Repulsion. Biomolecules, 10.","DOI":"10.3390\/biom10060828"},{"key":"ref_132","unstructured":"Evans, M.E., Allan, E.A., Horton, J., and Rooker, D.P. (2010). Aminopyridine Derivatives. (US20100076015A1), U.S. Patent."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and Drug-like Compounds: The Rule-of-Five Revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bmcl.2016.11.051","article-title":"Discovery of a New Isomannide-Based Peptidomimetic Synthetized by Ugi Multicomponent Reaction as Human Tissue Kallikrein 1 Inhibitor","volume":"27","author":"Barros","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1110\/ps.073333208","article-title":"Substrate Specificity of Human Kallikreins 1 and 6 Determined by Phage Display","volume":"17","author":"Li","year":"2008","journal-title":"Protein Sci."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e202500187","DOI":"10.1002\/cmdc.202500187","article-title":"Deferasirox Derivatives as Inhibitors of Kallikrein-Related Peptidases Associated to Neurodegenerative Diseases","volume":"20","author":"Boumali","year":"2025","journal-title":"ChemMedChem"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Courtney O\u2019Toole, C., Boakye, N.F., Hannigan, A., and Jalali, A. (2025). Clinical Impact of MRI-Based Risk Calculators for Prostate Cancer Diagnosis: A Systematic Review and Meta-Analysis. Prostate Cancer Prostatic Dis.","DOI":"10.1038\/s41391-025-01014-2"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Zhang, J., and Chadha, J.S. (2024). Developmental Therapeutics in Metastatic Prostate Cancer: New Targets and New Strategies. Cancers, 16.","DOI":"10.3390\/cancers16173098"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Borbiev, T., Kohaar, I., and Petrovics, G. (2024). Clinical Biofluid Assays for Prostate Cancer. Cancers, 16.","DOI":"10.3390\/cancers16010165"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.eururo.2014.10.021","article-title":"A Multi-Institutional Prospective Trial in the USA Confirms That the 4Kscore Accurately Identifies Men with High-Grade Prostate Cancer","volume":"68","author":"Parekh","year":"2015","journal-title":"Eur. Urol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1515\/BC.2006.092","article-title":"Human Tissue Kallikrein 9: Production of Recombinant Proteins and Specific Antibodies","volume":"387","author":"Memari","year":"2006","journal-title":"Biol. Chem."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1517\/14728222.2014.880693","article-title":"Targeting Kallikrein-Related Peptidases in Prostate Cancer","volume":"18","author":"Mavridis","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/pros.21111","article-title":"Prostate-Specific Antigen (PSA) Is Activated by KLK2 in Prostate Cancer Ex Vivo Models and in Prostate-Targeted PSA\/KLK2 Double Transgenic Mice","volume":"70","author":"Williams","year":"2010","journal-title":"Prostate"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1160\/TH13-04-0275","article-title":"Prostate Specific Kallikrein-Related Peptidases and Their Relation to Prostate Cancer Biology and Detection; Established Relevance and Emerging Roles","volume":"110","author":"Thorek","year":"2013","journal-title":"Thromb. Haemost."},{"key":"ref_145","first-page":"2257","article-title":"Pericellular Regulation of Prostate Cancer Expressed Kallikrein-Related Peptidases and Matrix Metalloproteinases by Cell Surface Serine Proteases","volume":"7","author":"Reid","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1160\/TH08-01-0025","article-title":"Treatment of PC3 Prostate Cancer Cells with Mitoxantrone, Etoposide, Doxorubicin and Carboplatin Induces Distinct Alterations in the Expression of Kallikreins 5 and 11","volume":"101","author":"Thomadaki","year":"2009","journal-title":"Thromb. Haemost."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1515\/hsz-2014-0149","article-title":"Analysis of Androgen and Anti-Androgen Regulation of KLK-Related Peptidase 2, 3, and 4 Alternative Transcripts in Prostate Cancer","volume":"395","author":"Lai","year":"2014","journal-title":"Biol. Chem."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1515\/hsz-2014-0150","article-title":"Loss of miR-378 in Prostate Cancer, a Common Regulator of KLK2 and KLK4, Correlates with Aggressive Disease Phenotype and Predicts the Short-Term Relapse of the Patients","volume":"395","author":"Avgeris","year":"2014","journal-title":"Biol. Chem."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Yu, K.-J., Ji, D.-Y., Hsieh, M.-L., Chuang, C.-K., Pang, S.-T., and Weng, W.-H. (2022). EPA Modulates KLK Genes via miR-378: A Potential Therapy in Prostate Cancer. Cancers, 14.","DOI":"10.3390\/cancers14112813"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/pros.24038","article-title":"Reduced KLK2 Expression Is a Strong and Independent Predictor of Poor Prognosis in ERG-Negative Prostate Cancer","volume":"80","author":"Bonk","year":"2020","journal-title":"Prostate"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000101311","article-title":"Epithelial-Mesenchymal Transition in Prostate Cancer and the Potential Role of Kallikrein Serine Proteases","volume":"185","author":"Lawrence","year":"2007","journal-title":"Cells Tissues Organs"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"E2572","DOI":"10.1073\/pnas.1304318110","article-title":"Molecular Circuit Involving KLK4 Integrates Androgen and mTOR Signaling in Prostate Cancer","volume":"110","author":"Jin","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1021\/acs.jproteome.5b01148","article-title":"Prostate Cancer-Associated Kallikrein-Related Peptidase 4 Activates Matrix Metalloproteinase-1 and Thrombospondin-1","volume":"15","author":"Stansfield","year":"2016","journal-title":"J. Proteome Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1074\/jbc.M005432200","article-title":"Molecular Cloning of the Human Kallikrein 15 Gene (KLK15): Up-Regulation in Prostate Cancer","volume":"276","author":"Yousef","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/psc.849","article-title":"Activity and Stability of Human Kallikrein-2-Specific Linear and Cyclic Peptide Inhibitors","volume":"13","author":"Pakkala","year":"2007","journal-title":"J. Pept. Sci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1515\/bc.2010.039","article-title":"Identification of IGFBP-3 Fragments Generated by KLK2 and Prevention of Fragmentation by KLK2-Inhibiting Peptides","volume":"391","author":"Hekim","year":"2010","journal-title":"Biol. Chem."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.bmcl.2016.01.039","article-title":"The Natural Flavone Fukugetin as a Mixed-Type Inhibitor for Human Tissue Kallikreins","volume":"26","author":"Santos","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"34267","DOI":"10.1074\/jbc.M114.598201","article-title":"Structure-Function Analyses of Human Kallikrein-Related Peptidase 2 Establish the 99-Loop as Master Regulator of Activity","volume":"289","author":"Skala","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.sbi.2012.05.006","article-title":"Conformational Selection in Trypsin-like Proteases","volume":"22","author":"Pozzi","year":"2012","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Jairajpuri, D.S., Hussain, A., Alajmi, M.F., Mohammad, T., Shamsi, A., and Hassan, I. (2025). Structure-Based Identification of Bioactive Phytochemicals Targeting Kallikrein-Related Peptidase 2 for Prostate Cancer Therapy. Front. Chem., 13.","DOI":"10.3389\/fchem.2025.1553987"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jmb.2007.11.052","article-title":"Crystal Structure of a Ternary Complex between Human Prostate-Specific Antigen, Its Substrate Acyl Intermediate and an Activating Antibody","volume":"376","author":"Michel","year":"2008","journal-title":"J. Mol. Biol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/pros.20773","article-title":"Novel Small Molecule Inhibitors for Prostate-Specific Antigen","volume":"68","author":"Koistinen","year":"2008","journal-title":"Prostate"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1515\/bc.2010.044","article-title":"Prostate-Specific Antigen: An Overlooked Candidate for the Targeted Treatment and Selective Imaging of Prostate Cancer","volume":"391","author":"LeBeau","year":"2010","journal-title":"Biol. Chem."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1021\/acsmedchemlett.4c00257","article-title":"Synthesis and Optimization of Small Molecule Inhibitors of Prostate Specific Antigen","volume":"15","author":"Erickson","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_165","first-page":"4924","article-title":"Specific and Efficient Peptide Substrates for Assaying the Proteolytic Activity of Prostate-Specific Antigen","volume":"57","author":"Denmeade","year":"1997","journal-title":"Cancer Res."},{"key":"ref_166","first-page":"2537","article-title":"Enzymatic Activation of a Doxorubicin-Peptide Prodrug by Prostate-Specific Antigen","volume":"58","author":"Denmeade","year":"1998","journal-title":"Cancer Res"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1016\/S0960-894X(02)00433-X","article-title":"A 5-Fluorodeoxyuridine Prodrug as Targeted Therapy for Prostate Cancer","volume":"12","author":"Mhaka","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_168","first-page":"451","article-title":"A Prostate-Specific Antigen (PSA)-Activated Vinblastine Prodrug Selectively Kills PSA-Secreting Cells in Vivo","volume":"1","author":"Brady","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/jnci\/djk065","article-title":"A Prostate-Specific Antigen-Activated Channel-Forming Toxin as Therapy for Prostatic Disease","volume":"99","author":"Williams","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1158\/1535-7163.MCT-07-0392","article-title":"A Prostate-Specific Antigen\u2013Activated N-(2-Hydroxypropyl) Methacrylamide Copolymer Prodrug as Dual-Targeted Therapy for Prostate Cancer","volume":"6","author":"Chandran","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1016\/j.bmc.2016.04.035","article-title":"Design and Synthesis of Peptide Conjugates of Phosphoramide Mustard as Prodrugs Activated by Prostate-Specific Antigen","volume":"24","author":"Wu","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1016\/j.bmc.2017.11.015","article-title":"Anticancer Activities of Emetine Prodrugs That Are Proteolytically Activated by the Prostate Specific Antigen (PSA) and Evaluation of in Vivo Toxicity of Emetine Derivatives","volume":"25","author":"Akinboye","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1016\/j.ejca.2010.08.018","article-title":"Development of a Novel Prodrug of Paclitaxel That Is Cleaved by Prostate-Specific Antigen: An in Vitro and in Vivo Evaluation Study","volume":"46","author":"Elsadek","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"17611","DOI":"10.1021\/acsomega.4c11483","article-title":"Development of a Prostate-Specific Antigen Targeted Dual Drug Conjugate for Prostate Cancer Therapy","volume":"10","author":"Owoseni","year":"2025","journal-title":"ACS Omega"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Isaacs, J.T., Brennen, W.N., Christensen, S.B., and Denmeade, S.R. (2021). Mipsagargin: The Beginning\u2014Not the End\u2014Of Thapsigargin Prodrug-Based Cancer Therapeutics. Molecules, 26.","DOI":"10.3390\/molecules26247469"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"22436","DOI":"10.18632\/oncotarget.25091","article-title":"PSA-Selective Activation of Cytotoxic Human Serine Proteases within the Tumor Microenvironment as a Therapeutic Strategy to Target Prostate Cancer","volume":"9","author":"Rogers","year":"2018","journal-title":"Oncotarget"},{"key":"ref_177","first-page":"300","article-title":"Therapeutic Metastatic Prostate Cancer Vaccines: Lessons Learnt from Urologic Oncology","volume":"74","author":"Lasek","year":"2021","journal-title":"Cent. Eur. J. Urol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s12032-025-03061-0","article-title":"Theranostics in Nuclear Medicine: The Era of Precision Oncology","volume":"42","author":"Gandhi","year":"2025","journal-title":"Med. Oncol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1200\/JCO-25-00678","article-title":"Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study","volume":"43","author":"Stein","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"ref_180","unstructured":"Clarke, H. (Urol. Times, 2025). FDA Grants Fast Track Designation to Pasritamig for mCRPC, Urol. Times."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2147\/ITT.S549873","article-title":"Prostate Cancer Immunotherapy: Time to Move Beyond Checkpoint Inhibitors","volume":"14","author":"Abel","year":"2025","journal-title":"Immunotargets Ther."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00262-011-1095-2","article-title":"Human Kallikrein 4 Signal Peptide Induces Cytotoxic T Cell Responses in Healthy Donors and Prostate Cancer Patients","volume":"61","author":"Wilkinson","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1158\/1078-0432.CCR-25-0950","article-title":"Human Kallikrein 2: A Novel Lineage-Specific Surface Target in Prostate Cancer","volume":"31","author":"Shen","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"31852","DOI":"10.1074\/jbc.M705190200","article-title":"Activation Profiles and Regulatory Cascades of the Human Kallikrein-Related Peptidases","volume":"282","author":"Yoon","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"25678","DOI":"10.1074\/jbc.M602372200","article-title":"Specificity Profiling of Seven Human Tissue Kallikreins Reveals Individual Subsite Preferences","volume":"281","author":"Debela","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1515\/BC.2008.075","article-title":"Structures and Specificity of the Human Kallikrein-Related Peptidases KLK 4, 5, 6, and 7","volume":"389","author":"Debela","year":"2008","journal-title":"Biol. Chem."},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Bartlett, J.D., and Simmer, J.P. (2014). Kallikrein-Related Peptidase-4 (KLK4): Role in Enamel Formation and Revelations from Ablated Mice. Front. Physiol., 5.","DOI":"10.3389\/fphys.2014.00240"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1515\/BC.2009.026","article-title":"A Completed KLK Activome Profile: Investigation of Activation Profiles of KLK9, 10, and 15","volume":"390","author":"Yoon","year":"2009","journal-title":"Biol. Chem."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1039\/C5MD00288E","article-title":"The First Potent Diphenyl Phosphonate KLK4 Inhibitors with Unexpected Binding Kinetics","volume":"6","author":"Gladysz","year":"2015","journal-title":"Med. Chem. Commun."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.peptides.2011.03.009","article-title":"Inhibition of Kallikrein-Related Peptidases by the Serine Protease Inhibitor of Kazal-Type 6","volume":"32","author":"Kantyka","year":"2011","journal-title":"Peptides"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbrc.2016.01.172","article-title":"The Solution Structure of the Kallikrein-Related Peptidases Inhibitor SPINK6","volume":"471","author":"Jung","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Swedberg, J.E., de Veer, S.J., Sit, K.C., Reboul, C.F., Buckle, A.M., and Harris, J.M. (2011). Mastering the Canonical Loop of Serine Protease Inhibitors: Enhancing Potency by Optimising the Internal Hydrogen Bond Network. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0019302"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"35385","DOI":"10.1038\/srep35385","article-title":"Direct and Indirect Mechanisms of KLK4 Inhibition Revealed by Structure and Dynamics","volume":"6","author":"Riley","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1021\/acs.biochem.9b00191","article-title":"KLK4 Inhibition by Cyclic and Acyclic Peptides: Structural and Dynamical Insights into Standard-Mechanism Protease Inhibitors","volume":"58","author":"Riley","year":"2019","journal-title":"Biochemistry"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1021\/acsmedchemlett.8b00422","article-title":"Potent, Selective, and Cell-Penetrating Inhibitors of Kallikrein-Related Peptidase 4 Based on the Cyclic Peptide MCoTI-II","volume":"9","author":"Swedberg","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"11436","DOI":"10.1038\/s41598-019-47615-5","article-title":"A Protein Scaffold, Engineered SPINK2, for Generation of Inhibitors with High Affinity and Specificity against Target Proteases","volume":"9","author":"Nishimiya","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1107\/S2059798321006483","article-title":"Structural Studies of Complexes of Kallikrein 4 with Wild-Type and Mutated Forms of the Kunitz-Type Inhibitor BbKI","volume":"77","author":"Li","year":"2021","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jmb.2006.08.003","article-title":"Crystal Structures of Human Tissue Kallikrein 4: Activity Modulation by a Specific Zinc Binding Site","volume":"362","author":"Debela","year":"2006","journal-title":"J. Mol. Biol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.0022-202X.2004.23547.x","article-title":"A Proteolytic Cascade of Kallikreins in the Stratum Corneum","volume":"124","author":"Brattsand","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1517\/14728222.2016.1147560","article-title":"Kallikrein-Related Peptidases (KLKs) as Emerging Therapeutic Targets: Focus on Prostate Cancer and Skin Pathologies","volume":"20","author":"Avgeris","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1111\/febs.70170","article-title":"Human Tissue Kallikrein 14 Induces the Expression of IL-6, IL-8, and CXCL1 in Skin Fibroblasts through Protease-Activated Receptor 1 Signaling","volume":"292","author":"Sasiadek","year":"2025","journal-title":"FEBS J."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.0022-202X.2004.22512.x","article-title":"Degradation of Corneodesmosome Proteins by Two Serine Proteases of the Kallikrein Family, SCTE\/KLK5\/hK5 and SCCE\/KLK7\/hK7","volume":"122","author":"Caubet","year":"2004","journal-title":"J. Investig. Dermatol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"32174","DOI":"10.1074\/jbc.M109.091850","article-title":"Isolation of SPINK6 in Human Skin: Selective Inhibitor of Kallikrein-Related Peptidases","volume":"285","author":"Wu","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1515\/hsz-2011-0238","article-title":"Characterization of SPINK9, a KLK5-Specific Inhibitor Expressed in Palmo-Plantar Epidermis","volume":"393","author":"Olofsson","year":"2012","journal-title":"Biol. Chem."},{"key":"ref_205","first-page":"354250","article-title":"Atopic Dermatitis: Natural History, Diagnosis, and Treatment","volume":"2014","author":"Thomsen","year":"2014","journal-title":"Int. Sch. Res. Not."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2022.06.004","article-title":"Aberrant Serine Protease Activities in Atopic Dermatitis","volume":"107","author":"Morizane","year":"2022","journal-title":"J. Dermatol. Sci."},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Furio, L., Pampalakis, G., Michael, I.P., Nagy, A., Sotiropoulou, G., and Hovnanian, A. (2015). KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome. PLoS Genet., 11.","DOI":"10.1371\/journal.pgen.1005389"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/jid.2009.435","article-title":"Kallikrein Expression and Cathelicidin Processing Are Independently Controlled in Keratinocytes by Calcium, Vitamin D3, and Retinoic Acid","volume":"130","author":"Morizane","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"32989","DOI":"10.1074\/jbc.R109.027946","article-title":"Functional Roles of Human Kallikrein-Related Peptidases","volume":"284","author":"Sotiropoulou","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.biochi.2015.09.023","article-title":"Kallikreins\u2014The Melting Pot of Activity and Function","volume":"122","author":"Kalinska","year":"2016","journal-title":"Biochimie"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ejmech.2013.10.040","article-title":"Identification by in Silico and in Vitro Screenings of Small Organic Molecules Acting as Reversible Inhibitors of Kallikreins","volume":"70","author":"Tan","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1021\/jm500988d","article-title":"Toward the First Class of Suicide Inhibitors of Kallikreins Involved in Skin Diseases","volume":"58","author":"Tan","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1107\/S2053230X19003169","article-title":"Evaluation of a Crystallographic Surrogate for Kallikrein 5 in the Discovery of Novel Inhibitors for Netherton Syndrome","volume":"75","author":"Thorpe","year":"2019","journal-title":"Acta Crystallogr. F Struct. Biol. Commun."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.jid.2021.01.029","article-title":"A Potent and Selective Kallikrein-5 Inhibitor Delivers High Pharmacological Activity in Skin from Patients with Netherton Syndrome","volume":"141","author":"Liddle","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1021\/acs.jmedchem.9b01806","article-title":"Structural Studies on the Inhibitory Binding Mode of Aromatic Coumarinic Esters to Human Kallikrein-Related Peptidase 7","volume":"63","author":"Hanke","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"9735","DOI":"10.1021\/acs.jmedchem.2c00306","article-title":"Phage Display Selected Cyclic Peptide Inhibitors of Kallikrein-Related Peptidases 5 and 7 and Their In Vivo Delivery to the Skin","volume":"65","author":"Gonschorek","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1016\/j.bmcl.2017.10.030","article-title":"Discovery and Structure\u2013Activity Relationship Study of 1,3,6-Trisubstituted 1,4-Diazepane-7-Ones as Novel Human Kallikrein 7 Inhibitors","volume":"27","author":"Murafuji","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bmcl.2018.11.011","article-title":"Discovery and Structure-Activity Relationship of Imidazolinylindole Derivatives as Kallikrein 7 Inhibitors","volume":"29","author":"Murafuji","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Chen, W., Kinsler, V.A., Macmillan, D., and Di, W.-L. (2016). Tissue Kallikrein Inhibitors Based on the Sunflower Trypsin Inhibitor Scaffold\u2014A Potential Therapeutic Intervention for Skin Diseases. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0166268"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"8050","DOI":"10.1002\/anie.202006919","article-title":"Sunflower Trypsin Inhibitor-1 (SFTI-1): Sowing Seeds in the Fields of Chemistry and Biology","volume":"60","author":"White","year":"2021","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jid.2016.09.017","article-title":"Selective Substrates and Inhibitors for Kallikrein-Related Peptidase 7 (KLK7) Shed Light on KLK Proteolytic Activity in the Stratum Corneum","volume":"137","author":"Furio","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/bip.21376","article-title":"Synthesis of the Proteinase Inhibitor LEKTI Domain 6 by the Fragment Condensation Method and Regioselective Disulfide Bond Formation","volume":"94","author":"Vasileiou","year":"2010","journal-title":"Biopolymers"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1515\/hsz-2018-0108","article-title":"Kallikrein-Related Peptidase 14 Is the Second KLK Protease Targeted by the Serpin Vaspin","volume":"399","author":"Ulbricht","year":"2018","journal-title":"Biol. Chem."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1111\/j.1742-4658.2006.05257.x","article-title":"Mutant Recombinant Serpins as Highly Specific Inhibitors of Human Kallikrein 14","volume":"273","author":"Felber","year":"2006","journal-title":"FEBS J."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408363.2020.1775171","article-title":"The Role of Kallikreins in Inflammatory Skin Disorders and Their Potential as Therapeutic Targets","volume":"58","author":"Diamandis","year":"2021","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Mella, C., Figueroa, C.D., Otth, C., and Ehrenfeld, P. (2020). Involvement of Kallikrein-Related Peptidases in Nervous System Disorders. Front. Cell. Neurosci., 14.","DOI":"10.3389\/fncel.2020.00166"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-8981(03)00004-4","article-title":"Role of Kallikrein Enzymes in the Central Nervous System","volume":"329","author":"Yousef","year":"2003","journal-title":"Clin. Chim. Acta"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/jnc.12293","article-title":"Kallikrein 6 Signals through PAR1 and PAR2 to Promote Neuron Injury and Exacerbate Glutamate Neurotoxicity","volume":"127","author":"Yoon","year":"2013","journal-title":"J. Neurochem."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5607\/en23014","article-title":"Advances in Amyloid-\u03b2 Clearance in the Brain and Periphery: Implications for Neurodegenerative Diseases","volume":"32","author":"Ullah","year":"2023","journal-title":"Exp. Neurobiol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"e70150","DOI":"10.1111\/jnc.70150","article-title":"Expression of Kallikrein in Glial Cells and Its Influence on Oligodendrocyte Myelination","volume":"169","author":"Tanaka","year":"2025","journal-title":"J. Neurochem."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12576-020-00753-2","article-title":"Neuropsin in Mental Health","volume":"70","author":"Bukowski","year":"2020","journal-title":"J. Physiol. Sci."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41419-023-05800-5","article-title":"Upregulation of KLK8 Contributes to CUMS-Induced Hippocampal Neuronal Apoptosis by Cleaving NCAM1","volume":"14","author":"Xu","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"jcs261422","DOI":"10.1242\/jcs.261422","article-title":"Neuropsin Promotes Hippocampal Synaptogenesis by Regulating the Expression and Cleavage of L1CAM","volume":"137","author":"Barman","year":"2024","journal-title":"J. Cell Sci."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/1753425914566083","article-title":"Expression and Bioregulation of the Kallikrein-Related Peptidases Family in the Human Neutrophil","volume":"21","author":"Lizama","year":"2015","journal-title":"Innate Immun."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1042\/BCJ20170174","article-title":"Biochemical and Functional Characterization of the Human Tissue Kallikrein 9","volume":"474","author":"Filippou","year":"2017","journal-title":"Biochem. J."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1097\/00001756-200108280-00031","article-title":"Expression of the Kallikrein Gene Family in Normal and Alzheimer\u2019s Disease Brain","volume":"12","author":"Yousef","year":"2001","journal-title":"NeuroReport"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"149217","DOI":"10.1016\/j.bbrc.2023.149217","article-title":"Kallikrein-Related Peptidase 10 Predicts Prognosis and Mediates Tumor Immunomodulation in Colorectal Cancer","volume":"689","author":"Luo","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"E9942","DOI":"10.1073\/pnas.1707658114","article-title":"The Immunopeptidomic Landscape of Ovarian Carcinomas","volume":"114","author":"Schuster","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"889","DOI":"10.4149\/neo_2020_190814N758","article-title":"Kallikrein-Related Peptidase (KLK10) Cessation Blunts Colorectal Cancer Cell Growth and Glucose Metabolism by Regulating the PI3K\/Akt\/mTOR Pathway","volume":"67","author":"Wei","year":"2020","journal-title":"Neoplasma"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/cbin.12113","article-title":"KLK10 Promotes the Progression of KRAS Mutant Colorectal Cancer via PAR1-PDK1-AKT Signaling Pathway","volume":"48","author":"Wu","year":"2024","journal-title":"Cell Biol. Int."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bbrc.2018.03.194","article-title":"Aberrant Upregulation of KLK10 Promotes Metastasis via Enhancement of EMT and FAK\/SRC\/ERK Axis in PDAC","volume":"499","author":"Cao","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1002\/jcb.26562","article-title":"NES1\/KLK10 Promotes Trastuzumab Resistance via Activation of PI3K\/AKT Signaling Pathway in Gastric Cancer","volume":"119","author":"Tang","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"79494","DOI":"10.18632\/oncotarget.13104","article-title":"Identification of KLK10 as a Therapeutic Target to Reverse Trastuzumab Resistance in Breast Cancer","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/sj.bjc.6600323","article-title":"Higher Expression of Human Kallikrein 10 in Breast Cancer Tissue Predicts Tamoxifen Resistance","volume":"86","author":"Luo","year":"2002","journal-title":"Br. J. Cancer"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.clinbiochem.2003.11.012","article-title":"Altered Kallikrein 7 and 10 Concentrations in Cerebrospinal Fluid of Patients with Alzheimer\u2019s Disease and Frontotemporal Dementia","volume":"37","author":"Diamandis","year":"2004","journal-title":"Clin. Biochem."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"146066","DOI":"10.1016\/j.ijbiomac.2025.146066","article-title":"Neuroprotective Functions of the APPI Domain of Amyloid Precursor Protein (APP): Reducing KLK6-Mediated APP Cleavage and A\u03b242 Formation and Aggregation","volume":"320","author":"Oren","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"104774","DOI":"10.1016\/j.neubiorev.2022.104774","article-title":"Kallikrein 8: A Key Sheddase to Strengthen and Stabilize Neural Plasticity","volume":"140","author":"Shiosaka","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/glia.23249","article-title":"Kallikrein 6 Secreted by Oligodendrocytes Regulates the Progression of Experimental Autoimmune Encephalomyelitis","volume":"66","author":"Bando","year":"2018","journal-title":"Glia"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/glia.24100","article-title":"Blocking Kallikrein 6 Promotes Developmental Myelination","volume":"70","author":"Yoon","year":"2022","journal-title":"Glia"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"110855","DOI":"10.1016\/j.intimp.2023.110855","article-title":"Inflammatory Regulation by Restraining M2 Microglial Polarization: Neurodestructive Effects of Kallikrein-Related Peptidase 8 Activation in Intracerebral Hemorrhage","volume":"124","author":"Tang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1515\/BC.2008.085","article-title":"Kallikreins Are Associated with Secondary Progressive Multiple Sclerosis and Promote Neurodegeneration","volume":"389","author":"Scarisbrick","year":"2008","journal-title":"Biol. Chem."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1515\/cclm-2017-0017","article-title":"Study of Kallikrein-Related Peptidase 6 (KLK6) and Its Complex with A1-Antitrypsin in Biological Fluids","volume":"55","author":"Korbakis","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1515\/hsz-2016-0205","article-title":"Structural Basis for the Zn2+ Inhibition of the Zymogen-like Kallikrein-Related Peptidase 10","volume":"397","author":"Debela","year":"2016","journal-title":"Biol. Chem."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1021\/ml200291e","article-title":"Virtual Screening and X-Ray Crystallography for Human Kallikrein 6 Inhibitors with an Amidinothiophene P1 Group","volume":"3","author":"Liang","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.bmcl.2012.02.014","article-title":"Human Kallikrein 6 Inhibitors with a Para-Amidobenzylanmine P1 Group Identified through Virtual Screening","volume":"22","author":"Liang","year":"2012","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1021\/acs.jmedchem.0c02175","article-title":"Identification of First-in-Class Inhibitors of Kallikrein-Related Peptidase 6 That Promote Oligodendrocyte Differentiation","volume":"64","author":"Deboux","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/cmdc.201900536","article-title":"Synthesis and Structure-Activity Relationships of N-(4-Benzamidino)-Oxazolidinones: Potent and Selective Inhibitors of Kallikrein-Related Peptidase 6","volume":"15","author":"Smits","year":"2020","journal-title":"ChemMedChem"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"26989","DOI":"10.1039\/D2RA04670A","article-title":"Scalable Synthesis and Structural Characterization of Reversible KLK6 Inhibitors","volume":"12","author":"Baumann","year":"2022","journal-title":"RSC Adv."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"8859","DOI":"10.1021\/acs.jmedchem.8b01106","article-title":"Depsipeptides Featuring a Neutral P1 Are Potent Inhibitors of Kallikrein-Related Peptidase 6 with On-Target Cellular Activity","volume":"61","author":"Lovell","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"12663","DOI":"10.1074\/jbc.RA117.000871","article-title":"A Potent, Proteolysis-Resistant Inhibitor of Kallikrein-Related Peptidase 6 (KLK6) for Cancer Therapy, Developed by Combinatorial Engineering","volume":"293","author":"Sananes","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1750-3639.2012.00577.x","article-title":"Kallikrein 6 Regulates Early CNS Demyelination in a Viral Model of Multiple Sclerosis","volume":"22","author":"Scarisbrick","year":"2012","journal-title":"Brain Pathol."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"e8184","DOI":"10.15252\/emmm.201708184","article-title":"Loss of Kallikrein-related Peptidase 7 Exacerbates Amyloid Pathology in Alzheimer\u2019s Disease Model Mice","volume":"10","author":"Kidana","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"113115","DOI":"10.1016\/j.expneurol.2019.113115","article-title":"Inhibition of Excessive Kallikrein-8 Improves Neuroplasticity in Alzheimer\u2019s Disease Mouse Model","volume":"324","author":"Keyvani","year":"2020","journal-title":"Exp. Neurol."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13195-018-0336-4","article-title":"Assessment of Kallikrein 6 as a Cross-Sectional and Longitudinal Biomarker for Alzheimer\u2019s Disease","volume":"10","author":"Patra","year":"2018","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1515\/BC.2008.158","article-title":"Regulation of Human Tissue Kallikrein-Related Peptidase Expression by Steroid Hormones in 32 Cell Lines","volume":"389","author":"Shaw","year":"2008","journal-title":"Biol. Chem."},{"key":"ref_266","doi-asserted-by":"crossref","unstructured":"Schauperl, M., Fuchs, J.E., Waldner, B.J., Huber, R.G., Kramer, C., and Liedl, K.R. (2015). Characterizing Protease Specificity: How Many Substrates Do We Need?. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0142658"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.1038\/s41598-018-24576-9","article-title":"Human Kallikrein-Related Peptidase 12 Stimulates Endothelial Cell Migration by Remodeling the Fibronectin Matrix","volume":"8","author":"Kryza","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_268","first-page":"1667","article-title":"Knockdown of KLK12 Inhibits Viability and Induces Apoptosis in Human Colorectal Cancer HT-29 Cell Line","volume":"44","author":"Li","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"110594","DOI":"10.1016\/j.msec.2019.110594","article-title":"Silencing KLK12 Expression via RGDfC-Decorated Selenium Nanoparticles for the Treatment of Colorectal Cancer in Vitro and in Vivo","volume":"110","author":"Xia","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1515\/BC.2007.049","article-title":"Enzymatic Properties of Human Kallikrein-Related Peptidase 12 (KLK12)","volume":"388","author":"Memari","year":"2007","journal-title":"Biol. Chem."},{"key":"ref_271","doi-asserted-by":"crossref","unstructured":"Maas, C., and de Maat, S. (2021). Therapeutic SERPINs: Improving on Nature. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.648349"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/jid.2013.502","article-title":"Characterization of Spink6 in Mouse Skin: The Conserved Inhibitor of Kallikrein-Related Peptidases Is Reduced by Barrier Injury","volume":"134","author":"Fischer","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1021\/acs.biochem.2c00573","article-title":"Identification of Kazal Inhibitor Scaffolds with Identical Canonical Binding Loops and Their Effects on Binding Properties","volume":"62","author":"Nagel","year":"2023","journal-title":"Biochemistry"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1515\/hsz-2020-0389","article-title":"Tissue Factor Pathway Inhibitor 2 Is a Potent Kallikrein-Related Protease 12 Inhibitor","volume":"402","author":"Lavergne","year":"2021","journal-title":"Biol. Chem."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Tissue-Based Map of the Human Proteome","volume":"347","author":"Fagerberg","year":"2015","journal-title":"Science"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.bbrc.2004.08.206","article-title":"Human Kallikrein 13 Involvement in Extracellular Matrix Degradation","volume":"323","author":"Kapadia","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cccn.2003.10.009","article-title":"Complex Formation between Human Kallikrein 13 and Serum Protease Inhibitors","volume":"339","author":"Kapadia","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1074\/jbc.M607567200","article-title":"A Potential Role for Multiple Tissue Kallikrein Serine Proteases in Epidermal Desquamation","volume":"282","author":"Michael","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0022-5347(05)64127-4","article-title":"Quantitative Analysis of Kallikrein 15 Gene Expression in Prostate Tissue","volume":"169","author":"Stephan","year":"2003","journal-title":"J. Urol."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.clinbiochem.2006.07.011","article-title":"Development of an Immunofluorometric Assay for Human Kallikrein 15 (KLK15) and Identification of KLK15 in Tissues and Biological Fluids","volume":"40","author":"Shaw","year":"2007","journal-title":"Clin. Biochem."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate Structure Prediction of Biomolecular Interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1093\/bioinformatics\/btt473","article-title":"lDDT: A Local Superposition-Free Score for Comparing Protein Structures and Models Using Distance Difference Tests","volume":"29","author":"Mariani","year":"2013","journal-title":"Bioinformatics"},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and Development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. Sect. D"},{"key":"ref_284","first-page":"11","article-title":"PyMOL: An Open-Source Molecular Graphics Tool","volume":"40","author":"DeLano","year":"2002","journal-title":"CCP4 Newsl."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1110\/ps.041080105","article-title":"Identification of the Ligand Binding Sites on the Molecular Surface of Proteins","volume":"14","author":"Kinoshita","year":"2005","journal-title":"Protein Sci."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1515\/hsz-2014-0140","article-title":"Sweetened Kallikrein-Related Peptidases (KLKs): Glycan Trees as Potential Regulators of Activation and Activity","volume":"395","author":"Guo","year":"2014","journal-title":"Biol. Chem."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"cwaf048","DOI":"10.1093\/glycob\/cwaf048","article-title":"Modeling Glycans with AlphaFold 3: Capabilities, Caveats, and Limitations","volume":"35","author":"Huang","year":"2025","journal-title":"Glycobiology"},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nbt1408","article-title":"Proteome-Derived, Database-Searchable Peptide Libraries for Identifying Protease Cleavage Sites","volume":"26","author":"Schilling","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12014-017-9140-6","article-title":"A New Enzyme-Linked Immunosorbent Assay (ELISA) for Human Free and Bound Kallikrein 9","volume":"14","author":"Filippou","year":"2017","journal-title":"Clin. Proteom."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0014-5793(75)80128-1","article-title":"The Single Calcium-Binding Site of Crystalline Bovine \u03b2-Trypsin","volume":"56","author":"Bode","year":"1975","journal-title":"FEBS Lett."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1158\/1078-0432.CCR-05-1696","article-title":"Purification and Characterization of Human Kallikrein 11, a Candidate Prostate and Ovarian Cancer Biomarker, from Seminal Plasma","volume":"12","author":"Luo","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1515\/BC.2007.124","article-title":"Defining the Extended Substrate Specificity of Kallikrein 1-Related Peptidases","volume":"388","author":"Gavigan","year":"2007","journal-title":"Biol. Chem."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1107\/S0907444913022269","article-title":"Duplex\u2013Quadruplex Motifs in a Peculiar Structural Organization Cooperatively Contribute to Thrombin Binding of a DNA Aptamer","volume":"69","author":"Pica","year":"2013","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00005-009-0045-6","article-title":"Reddish, Scaly, and Itchy: How Proteases and Their Inhibitors Contribute to Inflammatory Skin Diseases","volume":"57","year":"2009","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_295","doi-asserted-by":"crossref","unstructured":"Chen, L., Li, Q., Nasif, K.F., Xie, Y., Deng, B., Niu, S., Pouriyeh, S., Dai, Z., Chen, J., and Xie, C.Y. (2024). AI-Driven Deep Learning Techniques in Protein Structure Prediction. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25158426"},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"RP94029","DOI":"10.7554\/eLife.94029.3","article-title":"Reliable Protein\u2013Protein Docking with AlphaFold, Rosetta, and Replica Exchange","volume":"13","author":"Harmalkar","year":"2025","journal-title":"eLife"},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbpa.2018.05.003","article-title":"Cryptic Binding Sites on Proteins: Definition, Detection, and Druggability","volume":"44","author":"Vajda","year":"2018","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1080\/07391102.2017.1407674","article-title":"An Unexpected Switch in Peptide Binding Mode: From Simulation to Substrate Specificity","volume":"36","author":"Kahler","year":"2018","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/1062936X.2025.2543831","article-title":"Unravelling the Molecular Recognition Mechanism between Odorants and PBP1 in Loxostege Sticticalis by Homology Modelling, Molecular Docking, and MD Simulation","volume":"36","author":"Chen","year":"2025","journal-title":"SAR QSAR Environ. Res."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"100049","DOI":"10.1016\/j.insi.2025.100049","article-title":"Artificial Intelligence (AI) in Drug Design and Discovery: A Comprehensive Review","volume":"1","author":"Bhat","year":"2025","journal-title":"Silico Res. Biomed."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"20677","DOI":"10.1039\/D5SC05748E","article-title":"Incorporating Targeted Protein Structure in Deep Learning Methods for Molecule Generation in Computational Drug Design","volume":"16","author":"Vost","year":"2025","journal-title":"Chem. Sci."},{"key":"ref_302","doi-asserted-by":"crossref","unstructured":"Wang, Q., Sun, B., Yi, Y., Velkov, T., Shen, J., Dai, C., and Jiang, H. (2025). Progress of AI-Driven Drug\u2013Target Interaction Prediction and Lead Optimization. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262010037"},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.drudis.2018.09.002","article-title":"The Future of Drug Development: The Paradigm Shift towards Systems Therapeutics","volume":"23","author":"Danhof","year":"2018","journal-title":"Drug Discov. Today"},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"eadt1630","DOI":"10.1126\/science.adt1630","article-title":"Predicting Protein-Protein Interactions in the Human Proteome","volume":"390","author":"Zhang","year":"2025","journal-title":"Science"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/1\/225\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:51:43Z","timestamp":1766710303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/1\/225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":304,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["ijms27010225"],"URL":"https:\/\/doi.org\/10.3390\/ijms27010225","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]}}}